GlycoMimetics
GLYC
#10327
Rank
HK$78.84 M
Marketcap
HK$1.22
Share price
-5.42%
Change (1 day)
-45.86%
Change (1 year)

GlycoMimetics (GLYC) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : HK$20.36 Million

According to GlycoMimetics 's latest financial reports the company's total liabilities are HK$20.36 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlycoMimetics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$44.85 M-16.79%
2023-12-31HK$53.9 M-22.31%
2022-12-31HK$69.38 M-30.17%
2021-12-31HK$99.36 M-12.28%
2020-12-31HK$0.11 B5.64%
2019-12-31HK$0.10 B46.07%
2018-12-31HK$73.41 M5.79%
2017-12-31HK$69.39 M26.27%
2016-12-31HK$54.95 M-11.26%
2015-12-31HK$61.93 M23.59%
2014-12-31HK$50.11 M171.98%
2013-12-31HK$18.42 M-59.65%
2012-12-31HK$45.66 M-71.25%
2011-12-31HK$0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
bluebird bio
BLUE
HK$2.75 B 13,420.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$899.84 B 4,418,627.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$513.80 B 2,522,974.75%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
HK$883.53 B 4,338,533.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$78.71 M 286.54%๐Ÿ‡บ๐Ÿ‡ธ USA